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Abstract 
A relative lack of literature exists regarding the relationship between sexual functioning 
and sleep quality in women. The current study assessed these constructs in a sample of 
260 undergraduate female students via online administration of relevant measures for 
sleep quality, sexual functioning, stress, and medical conditions and prescription 
medications. The relationship between sleep quality and sexual functioning was positive 
but not significant, even when controlling for relevant variables such as stress. As such, 
future research might seek to clarify this relationship and to identify variables that 
mediate or moderate this relationship.  
 Keywords: sleep quality, sexual functioning, stress, medical conditions 
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Introduction 
 Though both sexual activity and sleep are nearly ubiquitous biological processes, 
little research has been conducted examining the relationship between the two. This is 
especially the case for women. A majority of research involving sleep quality and sexual 
functioning centers on sexual correlates of specific sleep disorders in men, making such 
research about women conspicuous by its absence. The most prominent sleep disorder 
addressing sleep and sex in the scientific literature is obstructive sleep apnea (OSA), a 
disorder characterized by repeated periods of irregular or halted breathing during sleep 
due to upper airway obstruction (Arruda-Olson, Olson, Nehra, & Somers, 2003). This 
preponderance of research about men might be less a result of androcentrism than of 
patient demographics; the prevalence of OSA is approximately 3 to 7% for adult men but 
2 to 5% for adult women (Punjabi, 2008). However, the American Academy of Sleep 
Medicine (2014) estimated that at least 25 million Americans currently suffer from OSA, 
and that 26% of American adults between the ages of 30 and 70 might suffer from OSA. 
Though OSA is the most often-researched sleep disorder for which sexual functioning is 
assessed by a wide margin, it not the only sleep disorder with sexual symptomatology; 
sexual dysfunction is a common symptom of many disorders of the sleep cycle. For 
instance, individuals with narcolepsy, a sleep disorder that causes excessive daytime 
sleepiness, REM sleep disturbances, and sleep paralysis, frequently suffer from sexual 
dysfunction (Penn State Hershey Medical Center, 2013). The classic narcolepsy 
symptoms of daytime sleepiness and an overwhelming need for sleep may reduce libido 
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and sexual functioning, as biological resources are prioritized toward sleep. Additionally, 
the fact that nocturnal erections occur in REM sleep and REM sleep is disrupted in 
narcolepsy cannot be ignored, though few studies have assessed sexual functioning in 
narcolepsy even prospectively. 
OSA and Sexual Functioning in Men 
 A boon to research about OSA in men is its established relationship with an 
objective biological indicator of male sexual functioning: Erectile dysfunction (ED). 
Erection is a phenomenon acted upon by many biological mechanisms, such as neural 
processes of brain regions associated with responsive sexual arousal, autonomic nervous 
system activation, neurochemical release, and vasodilation (Awad, Alsaid, Bessede, 
Droupy, & Benoît, 2011). In terms of ED treatment in OSA, Perimenis et al. (2004) 
found that ED symptoms improved more in men taking sildenafil (i.e., Viagra) than in 
men using nightly continuous positive airway pressure (CPAP) over 12 weeks, and thus 
suggested that ED might be better managed through ED-specific pharmaceuticals such as 
sildenafil than through treatment of the underlying condition itself. Though sildenafil 
appears to relieve symptomatic concerns of ED more than CPAP because of its direct 
mechanism of action (acting on one culpable enzyme versus increasing oxygenation of 
blood through continuous breathing), this pharmacology does not attempt to correct 
nightly hypoxic episodes that might lead to the enzymatic dysregulation upon which 
sildenafil acts.  
 Though sildenafil appears effective at treating the OSA symptom of ED, CPAP is 
designed to treat OSA itself. Treatment with CPAP has been found to be more effective 
than antidepressant medications alone in the treatment of ED in men with severe OSA 
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(Taskin et al., 2010). These findings support the improvement of ED in patients under 
CPAP treatment observed by Perimenis et al. (2004) and suggest that CPAP might be a 
particularly effective treatment for ED in individuals with a more severe OSA 
presentation, especially with long-term treatment adherence. Long-term CPAP use has in 
fact been associated with an improvement in overall sexual life satisfaction (Petersen, 
Kristensen, Berg, & Midgren, 2013). Potential barriers to CPAP treatment adherence 
include discomfort with the CPAP mask and device, difficulty maintaining a routine or 
generalizing treatment, and concern over negative reactions to the device from bed 
partners. 
Sleep Quality and Sexual Functioning in Women 
 Though sexual dysfunction in OSA is well described in men, it is not defined as 
well for women (Subramanian et al., 2010). Research about sexual functioning in men 
centers on the more objective symptom of ED, but research using objective measures of 
sexual arousal in women is lacking. Women with OSA have lower levels of progesterone, 
estradiol, and 17-OH-progesterone than healthy controls when matched for age and 
menstrual cycle phase (Netzer, Eliasson, & Strohl, 2003), suggesting that some 
combination of mechanisms with OSA contribute to sex hormone dysregulation in 
women. Despite this finding, physical measures of sexual dysfunction in women are not 
widely utilized. One possible method of examining the relationship between sleep 
disorders and sexual functioning that would use objective measures is measuring vaginal 
vasocongestion with a vaginal photoplethysmograph, though objective results of this 
device do not always correspond to women’s subjective reports of sexual arousal (Laan, 
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Everaerd, & Evers, 1995). Thus, this method might be limited to only comparing 
vasocongestion between women with and without OSA. 
 Köseoğlu et al. (2007) were the first to examine the specific relationship between 
sexual functioning and disordered sleep symptoms, including sleepiness, in women with 
OSA. Twenty-five patients were trichotomized into mild, moderate, or severe OSA 
groups based on their respiratory disturbance index from polysomnography. 
Demographic information, medical history, polysomnography results, and frequency of 
intercourse per month for patients were assessed, and patients completed the Sexual 
Function Questionnaire Version 2 and the Epworth Sleepiness Scale. Köseoğlu et al. 
found significantly decreasing scores on the Sexual Function Questionnaire domains of 
Desire (p = .007), Sensation (p = .006), Lubrication (p = .045), Orgasm (p = .026), and 
Partner Relationship (p = .023) as severity of OSA increased. However, the domain 
scores of Pain and Enjoyment did not significantly change across OSA severity groups. 
Thus, Köseoğlu et al. posited that OSA negatively affects sexual functioning in women 
independent of age or comorbid conditions.  
 Subramanian et al. (2010) extended the examination of sexual functioning among 
women with OSA. Twenty-one premenopausal women with OSA and eleven healthy 
premenopausal women were administered the Female Sexual Function Index (FSFI) and 
the Profile of Mood States scale. Total scores on the FSFI below 23, indicating less 
satisfactory sexual functioning, were labeled poor. Though the group means for the mood 
scale of women with OSA and controls were not significantly different, eleven of the 21 
OSA patients had poor FSFI scores but none of the control participants had poor scores. 
Further analysis of FSFI domain scores found that the domains of Arousal, Lubrication, 
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Orgasm, Satisfaction, and Pain, as well as total FSFI score, were significantly lower in 
women with OSA than in healthy controls. Only the domain of Desire was not 
significantly lower in OSA patients. Subramanian et al. noted agreement between their 
findings and those of Köseoğlu et al. (2007), in that both demonstrated a high prevalence 
of decreased sexual functioning in women with OSA.  
Biological Factors of Sleep Quality and Sexual Functioning 
 Both sleep and sexual activity are biologically endogenous and maintained 
processes.  Thus, sleep or sexual dysfunction indicates the presence of biological 
dysregulation, regardless of whether the etiology of the sleep or sexual dysfunction was 
organic or psychogenic. Other factors affecting both sleep quality and sexual functioning 
include chronic pain conditions and pharmaceutical treatments. 
 Sleep quality. Sleep is typically entrained to occur on an approximately 24-hour 
circadian rhythm, with an optimal sleep duration of seven to nine hours for adults. 
However, this cycle is maintained or influenced by exogenous environmental cues called 
Zeitgebers (Kooij & Bijlenga, 2013). Examples of Zeitgebers are ambient light or 
sunlight, temperature, exercise, diet, and pharmaceutical treatments. Alterations to any 
Zeitgebers affect the human body’s natural circadian rhythm and can entrain a new 
rhythm based on ambient cues (Kooij & Bijlenga, 2013). Sleep is neurologically 
generated and maintained, with circadian rhythm control arising from a small region of 
the hypothalamus called the suprachiasmatic nucleus (Moore, Speh, & Leak, 2002). This 
region is situated in close proximity to the optic nerves and receives cues from ambient 
light, then transmits information about daily light patterns to the pineal gland. The pineal 
gland in turn secretes the chemical melatonin in a circadian fashion with higher secretion 
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levels at night (Kooij & Bijlenga, 2013). Melatonin promotes sleep in anticipation of 
darkness. Thus, light as a Zeitgeber appears to be integral to sleep rhythm maintenance.  
 The American Academy of Sleep Medicine divides sleep into four separate stages 
(Silber et al., 2007). These four stages are neurologically induced during typical sleep, 
and they follow a relatively consistent cycle each night given a stable circadian rhythm. 
These stages are further subdivided based on the type of sleep that occurs during that 
stage: Rapid eye movement (REM) sleep or non-REM (NREM) sleep, and the stages are 
largely defined by the frequency of electrical activity in the brain. Stage 1 is the first 
NREM stage and is defined by the transition between wakefulness and sleep. Stage 2 is 
the second NREM stage, in which the sleeper is more difficult to awaken. Stage 3 is the 
third NREM stage often colloquially referred to as “deep sleep.” In Stage 3 sleep, the 
sleeper exhibits sharply decreased responsiveness to environmental cues. The final stage 
is REM sleep, in which the sleeper’s muscles are almost totally paralyzed and the eyes 
quickly move. This stage has a relatively high volume of dreams compared to NREM 
sleep stages, and neural activity resembles that of an individual who is awake. Humans 
typically descend from wakefulness into Stages 1 through 3, then experience REM sleep 
as they ascend into a period of brief wakefulness; this cycle repeats a few times each 
night with REM periods increasing in duration and Stage 3 decreasing as the night 
continues, with each cycle lasting approximately 90 to 110 minutes (National Institute of 
Neurological Disorders and Stroke, 2014). Though the basic structure of sleep cycles is 
the same across humans, sleep is by no means monolithic. Gender differences related to 
sleep maintenance have been documented in several examinations of sleep in men and 
women. For instance, women report longer sleep durations than men, especially in 
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adulthood (Basner et al., 2007; Burgard & Ailshire, 2012). In the case of college 
undergraduate women, sleep duration has also been found to increase as the semester 
progresses (Liguori, Schuna, & Mozumdar, 2011); however, subjective feelings of 
restfulness upon wakening were reported by less than half of all participants of both 
genders despite a sufficient mean sleep duration. Research regarding gender differences 
in sleep processes, especially in terms of sleep duration and sleep quality, has heretofore 
been conducted through psychosocial and interpersonal lenses.  
 As it is a biological imperative, sleep is a requisite for the maintenance of both 
physical and mental health. Sleep debt can have a cumulative, deleterious effect on 
human psychological and physiological processes, including emotion, cognitive function, 
and physical health. A consistent sleep cycle is thus vital to better overall health and is 
essential if better sleep quality is to be obtained. Though not all individuals who 
experience sufficient sleep duration or stages will feel well rested, proper physiological 
maintenance is dependent on the sufficient occurrence of sleep stages. In OSA, sufferers 
briefly stop breathing during sleep, decreasing blood oxygenation and waking the sufferer 
perhaps dozens of times during a typical night’s sleep. This disrupts the sleep stages, 
affecting the physiological regulatory mechanisms that occur in a proper sleep cycle. 
Insomnia sufferers cannot fall asleep, interrupting their naturally entrained circadian 
rhythms, and often turn to Zeitgebers such as pharmaceuticals to induce sleep. 
Narcolepsy sufferers often drop into REM sleep within a few minutes of sleep onset 
instead of progressing through the NREM stages first, which disrupts the typical sleep 
cycle. This shortens the amount of time spent in Stage 2 and 3 during a given night, and 
the daytime sleepiness and REM disturbances are compensatory for altered nighttime 
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sleep. Sleep disorders are thus a reflection of dysregulation of the natural sleep cycle 
produced endogenously, though methods of compensation such as caffeine and 
psychological states such as anxiety or depression might catalyze, propagate, or 
exacerbate this dysregulation.  
 However, it must be said that a sleep disorder diagnosis is not a prerequisite for 
unsatisfactory sleep quality. Sleep quality as its own construct involves elements of sleep 
duration, sleep hygiene, and subjective feelings of restfulness; because of the 
multifaceted nature of sleep, with environmental, psychological, and biological 
mechanisms at work, sleep quality should be a continuum-based construct. Instead of an 
individual having either typical or disordered sleep, this continuum would allow each 
individual to place her sleep quality on a line between complete dissatisfaction and 
complete satisfaction with sleep.  
 Sexual functioning. Sexual arousal is a cascade of physiological and 
psychological responses that prepare the body for sexual activity in response to external 
or internal cues such as sexual stimulation or fantasizing. In women, the biological 
mechanisms of sexual arousal include vaginal lubrication and engorgement of the 
genitals, which are mediated by vasodilation and reflexive nervous system responses and 
feedback (Kim, Christianson, & Traish, 2004). Dysfunctions in these physiological 
processes are criteria for the diagnosis of Female Sexual Interest/Arousal Disorder in the 
DSM-5 (American Psychiatric Association, 2013), which combines symptoms of 
decreased biological response with decreased subjective sexual interest. Because of the 
complexity of both the biological and psychological mechanisms of arousal, sexual 
functioning is also best conceptualized as a continuum, with complete inability to become 
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aroused on one end and appropriate and sufficient arousal on the other. This contrasts 
with the historically categorical, binary diagnostic model of sexual functioning, in which 
a woman either had sexual dysfunction or did not.  
 Chronic pain conditions. Chronic pain is an incredibly prevalent health concern 
affecting many aspects of quality of life, including sexual functioning and sleep. The 
American Academy of Pain Medicine (2006) estimates that 100 million Americans suffer 
from some form of chronic pain, equating to over 30% of Americans. Headache is among 
the most prevalent chronic pain disorders, with migraine headache being of particular 
concern. Migraines affect 12% of Americans annually; an estimated 17% of women and 
5.5% of men experience migraines, reflecting a three-to-one female-to-male prevalence 
ratio (Smitherman, Penzien, & Rains, 2013). Other common chronic pain conditions 
affect the low back, neck, and facial nerves. 
 Because of both the severity and duration of chronic pain, global quality of life is 
often affected. A common sequela of chronic pain is insomnia, in which the pain 
sensations are so severe or irritating that sleep cannot be adequately achieved. 
Additionally, chronic pain sufferers tend to fear an increase in their pain and 
consequently avoid exercise, further exacerbating both sleep dysfunction and pain levels. 
This is problematic, as two of the frontline behavioral treatments of chronic pain are 
improved sleep hygiene and increased exercise levels. Decreased sleep quality, lack of 
appropriate exercise, and pain state exacerbation thus contribute to a cyclical model of 
pain maintenance.  
 Depending on the level of impairment from either a primary medical condition 
with secondary pain or primary pain itself, sexual functioning may also be affected. 
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Individuals with neuropathic pain may have hypersensitivity to touch, in which typically 
neutral or erotic touch may be painful or irritating, or they may experience decreased 
sensitivity in erogenous areas. As reflexive nervous system response and feedback are 
critical in the initiation and maintenance of sexual arousal, pain conditions caused by 
nerve dysfunction may interrupt the arousal input-output loop, causing decreases in 
subjective or physiological arousal levels. In this case, neurological deficits are directly 
interfering with sexual functioning, and the primary subjective result of these deficits is 
pain. Mechanical pain conditions caused by injury or illness may limit sexual activity 
based on affected areas as well; for instance, an individual with degenerative disc disease 
may be too distressed by his low back pain to mechanically achieve an erection or 
maintain it during sexual activity. If it is the case that there is little to no neurological 
dysfunction present, chronic pain may influence sexual function through psychological 
factors, e.g., pain as distraction or anxiety about performance. 
 Pharmaceutical factors. In an effort to alleviate symptoms of sexual dysfunction 
or poor sleep quality, the first-line treatment is often medication. Sexual dysfunction in 
women is notoriously difficult to treat with pharmaceuticals, though the effectiveness of 
medications such as sildenafil is being evaluated (e.g., Alexander et al., 2011). This is in 
stark contrast to ED in men, which is typically alleviated rapidly by medications such as 
sildenafil, tadalafil (Cialis), or vardenafil (Levitra). Though these medications do not treat 
underlying causes of sexual dysfunction, they can improve ED symptoms in the short-
term, and may provide some benefit to women in the future. 
 Medications that promote or alter sleep are often prescribed to treat a variety of 
sleep symptoms and disorders, including insomnia and excessive daytime sleepiness. 
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Benzodiazepine medications such as clonazepam, alprazolam, and diazepam are often 
prescribed as hypnotics to induce sleep, but over longer administrations, these 
medications have an increasing risk of dependency. These medications are thus intended 
to break the cycle of sleeplessness in the short term as the sufferer makes lifestyle 
changes for symptom improvement and weans off the medicine. Nonbenzodiazepine 
hypnotic medications such as zolpidem and eszopiclone are similarly prescribed to 
induce sleep, and while these medications are less addictive than benzodiazepines, they 
still carry abuse potential if consumed above recommended dosage (Lajiness, 2008; 
Victorri-Vigneau et al., 2013). Conversely, individuals with circadian rhythm disruptions 
or excessive daytime sleepiness are often prescribed modafinil, a wakefulness-promoting 
medication, which is functionally opposite the hypnotics listed above. Medications such 
as modafinil are not inherently habit-forming, allowing reprieve from intrusive sleep in 
the long term. 
 Medications prescribed to treat chronic pain can affect both sleep quality and 
sexual functioning. Opioid narcotic medications can be highly effective treatments for 
acute or chronic pain, but opioids have also been linked to sexual dysfunction (Christo, 
2003). Additionally, narcotic medications and other medications for chronic pain such as 
tricyclic antidepressants have sedative or hypnotic properties. While this may benefit 
those with comorbid chronic pain and insomnia, these medications act as Zeitgebers and 
influence the circadian rhythm. 
 Antidepressant medications such as selective serotonin reuptake inhibitors are 
often prescribed for chronic pain management, but are infamously linked with sexual side 
effects. Montejo, Llorca, Izquierdo, and Rico-Villademoros (2001) investigated the 
SEXUAL FUNCTIONING AND SLEEP QUALITY 12 
incidence of sexual dysfunction among outpatients with previously typical sexual 
functioning who were treated with any of ten antidepressant medications, and found that 
the overall incidence of reported sexual dysfunction among these outpatients was 59.1%. 
Men (62.4%) reported sexual side effects more frequently than women (56.9%), but 
women reported more severe dysfunction. This indicates that the mechanism of action in 
these medications has a deleterious physiological effect on sexual functioning. 
Purpose of Study 
 By far, the most common sleep disorder researched with regard to sexual 
functioning in women is OSA. Though research on OSA has yielded findings that support 
a relationship between sleep and sexual functioning, it is only through the lens of a 
specific sleep disorder; thus, sexual functioning is only being assessed with respect to 
OSA’s specific sleep symptomatology. There is a substantial lack of literature examining 
sleep quality and sexual functioning in nonclinical women without prediagnosed sleep or 
sexual disorders as a requirement for participation.  
 Accordingly, the researchers aim to investigate whether a relationship exists 
between sleep quality and sexual functioning in a nonclinical sample of female 
undergraduate students. The current study will be an analysis of the participants’ self-
reported sleep quality and sexual functioning ratings. If a relationship between these 
variables is supported, future research can extend this finding to more diverse samples of 
women for generalizability. Additionally, future research might attempt to construct a 
more complex model of sleep quality and sexual functioning in women, which could 
support either a direction of biological causality or a reciprocal relationship of sleep and 
sex. If this relationship exists and can be better understood, quality of life might be 
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improved for women with poor sleep quality, less satisfactory sexual functioning, or 
both. 
Methods 
Participants 
 Participants in the present study were female undergraduate students at Minnesota 
State University, Mankato (N = 260). Institutional approval for the present study was 
obtained from Minnesota State University, Mankato on January 28, 2015. To be included 
in the present study, participants were required to be enrolled at Minnesota State 
University, Mankato, and be biological female.  
Procedures 
 Participants accessed the present study through SONA systems hosted on the 
Minnesota State University, Mankato psychology department website. Completion of the 
current study made participants eligible for course extra credit. The present study 
consisted of informed consent (see Appendix A); eight demographics items (see 
Appendix B); the nineteen-item FSFI (2000, see Appendix C); a novel checklist for 
general medical conditions and medications (see Appendix D); the 26-item Pittsburgh 
Sleep Quality Index (PSQI; University of Pittsburgh, 1989, see Appendix E); and the 
College Student’s Stressful Events Checklist (CSSEC; Holmes & Rahe, 1967, see 
Appendix F). Total time of administration of these items was approximately 20 minutes. 
Psychometric Properties of Included Measures 
 FSFI. The FSFI is a widely used measure of female sexual functioning variables, 
assessing domains of desire, arousal, lubrication, orgasm, satisfaction, and pain. The 
domains of the FSFI have been found to have high test-retest reliability (r = .79 to .86) 
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and internal consistencies of 0.82 or higher (Rosen et al., 2000). Wiegel, Meston, and 
Rosen (2005) similarly found high internal consistency for the total FSFI and domain 
scores among a combined dysfunctional and nondysfunctional sample (αs < .9). Mean 
differences between female sexual arousal disorder sufferers and controls have also been 
found to be highly significant for all domains, suggesting high construct validity (p ≤ 
.001; Rosen et al., 2000).  
 PSQI. The PSQI is commonly administered to assess individuals on seven 
components: Subjective sleep quality, sleep latency, sleep duration, habitual sleep 
efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The 
PSQI demonstrates acceptable internal homogeneity and validity, and high diagnostic 
specificity and sensitivity (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989). 
Cronbach’s alpha for the global PSQI score has been indexed at .87 for individuals with 
primary insomnia (Backhaus, Junghanns, Broocks, Riemann, & Hohagen, 2002) and at 
.77 to .81 for cancer patients (Beck, Schwartz, Towsley, Dudley, & Barsevick, 2004), 
indicating that the PSQI demonstrates high internal consistency.  
 CSSEC. Holmes and Rahe (1967) developed the CSSEC as a measure of 
cumulative stress with higher specificity for young adults, specifically for college 
students, as some of the stressors included in their prominent Social Readjustment Rating 
Scale (1967) did not apply to typical events in a college student’s life. The goal of the 
CSSEC is to determine relative risk of illness due to cumulative life stress. Holmes and 
Rahe applied weights to each item on the CSSEC to adjust for disparities in level of 
distress caused by each item; however, it must be stated that subjective levels of distress 
differs between individuals. For instance, having to drop more than one class in a 
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semester might be very distressing to some students, but might have little effect on 
others. Scores are then trichotomized into three stress levels based on their scores, with 
scores below 150 indicating mild stress and scores above 300 indicating severe stress.  
Results 
 The sample consisted of 260 female undergraduate students. Descriptive 
frequency data for participants’ race/ethnicity and sexual orientation are provided in 
Table 1. It must be noted that demographic variables such as race/ethnicity, sexual 
orientation, and year in school were presented as open-ended responses for participants; 
as such, the categories presented in these tables reflect coded groups based on common 
responses (e.g., straight and heterosexual coded as heterosexual). Five participants were 
excluded from analysis due to identifying their gender as male; one participant was 
excluded because of identifying as a graduate student; two participants were excluded for 
being below age 18; and seven participants were excluded on the basis of responses to 
less than ten items.  
 The relationship between sleep quality and sexual functioning as quantified by the 
PSQI global score and the FSFI total score was analyzed with a Pearson r correlation. 
The relationship between these two measures was not significant, r = -.100, p = .120. A 
partial correlation controlling for weighted responses to the CSSEC and participant age 
increased the magnitude of this relationship, though it remained nonsignificant, r = -.125, 
p = .054. A regression model additionally controlling for sleep disorder diagnoses, 
anxiety medications, and antidepressant medications indicated no significant relationship 
between FSFI and PSQI scores, p = .075. 
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 Though the hypothesized relationship of PSQI and FSFI scores was not 
significant, other significant relationships between relevant variables were found. Scores 
on the PSQI and CSSEC were positively correlated, r = .325, p < .001, indicating that 
higher cumulative weighted stress levels were significantly related to higher levels of 
sleep dysfunction. Age was significantly correlated with FSFI total scores, r = .159, p = 
.013, indicating a positive relationship between age and sexual functioning such that 
increasing age was indicative of more satisfactory sexual functioning. Similarly, a one-
way, between-groups ANOVA indicated that school class was significantly associated 
with FSFI total scores, F(4, 237) = 3.836, p = .005; LSD post-hoc analysis found that 
most significant difference between classes in terms of FSFI total scores was between 
freshmen (M = 19.22) and seniors (M = 24.80), p = .001. 
Discussion 
 The primary research hypothesis of the current study was not supported. Though 
the correlation between scores trended in the hypothesized negative direction with more 
satisfactory sexual functioning indicating better sleep quality, the relationship between 
FSFI and PSQI global scores was not significant. This relationship remained 
nonsignificant even when relevant variables were controlled for, hinting at the existence 
of at least one other variable that mediates the relationship between sleep quality and 
sexual functioning but was not examined in the current study. It is also possible that the 
variables that were controlled for were not adequately addressed by the measures 
administered in the current study. For instance, only the presence of illnesses like 
neurological or sleep disorders was assessed instead of assessing presence and severity. If 
it is the case that no set of mediating variables exists, the nonsignificant relationship from 
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the current study suggests that in a nonclinical sample of undergraduate women, sleep 
quality and sexual functioning might not be interconnected constructs. These constructs 
might be more closely related in older women, in a clinical sample such as in women 
with OSA, or in a sample of both genders if appropriate sexual functioning measures 
were to be administered. However, it cannot be disregarded that a trend appears to exist 
between these variables; while not statistically significant, there is the possibility that this 
relationship may feel significant for some individuals such that intervention strategies for 
the improvement of sleep quality or sexual functioning might be warranted. 
Additional Analyses  
 Another consideration for the current study is that the FSFI might pathologize a 
participant’s lack of sexual activity in the past four weeks by scoring it as a 0 on any 
relevant item, thereby decreasing her global score drastically and implying a lower level 
of sexual functioning. This might yield FSFI global scores that are not indicative of true 
functioning; a woman who has not engaged in sexual activity in the past four weeks 
might have very satisfactory sexual functioning, but her FSFI global score does not 
reflect this. Very low scores on the FSFI yielded by this response pattern might also 
greatly affect analyses and group means. This is evident in the one-way ANOVA for 
school class by FSFI global score, in which group means for all classes are below the 
suggested cutoff score of 26, indicating that all classes exhibit clinical levels of sexual 
dysfunction, which is unexpected in a nonclinical sample of undergraduate female 
students. Using a nested model to control for participants who are abstinent might give a 
better picture of functioning in those who have engaged in sexual activity in the past four 
weeks and thus have substantial FSFI scores. 
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 Religiosity was only accessed with one item in the survey package, but examining 
responses on this item and the relationship with zero-responses on the FSFI could be a 
potentially illuminating analysis. This would indicate whether women who agree that 
religion is important in their lives are more likely to respond that they have not engaged 
in sexual activity in the past four weeks. Interaction effects with medications and sexual 
functioning could also be tested to determine whether the presence of medications, or the 
use of multiple medications, influence global FSFI scores. 
Limitations 
 The current study does not address all possible covariates of sleep quality and 
sexual functioning. Generalizability to all women is limited by the undergraduate 
convenience sample, so results may not apply to women in other regions of the United 
States or to women of ages different than typical undergraduate age. However, 
generalizability would be acceptable for colleges with similar demographics. Though the 
goal of the current study is to assess the relationship between sleep quality and sexual 
functioning in a nonclinical population, endorsing a sleep or sexual disorder diagnosis 
did not preclude participation. 
Future Directions 
 As the current study does not indicate a significant relationship between sleep 
quality and sexual functioning, future research could aim to establish covariates and to 
further seek mediating or moderating variables. These findings could elucidate any 
variables that modify the relationship between sleep quality and sexual functioning. 
Moreover, individual findings that were supported by the current study might also be 
targets of future research because they could have practical use as intervention strategies 
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for undergraduate students. For instance, the negative relationship between stress and 
sleep quality indicated in the current study could be elaborated upon for the purpose of 
decreasing cumulative stress levels and increasing sleep quality for undergraduate 
students. 
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Table 1 
 Descriptive frequency and percent statistics for reported race/ethnicity and sexual 
orientation. 
Variable  Frequency Percent 
Race / Ethnicity   
 White/Caucasian 218 83.8 
 Asian 12 4.6 
 Hispanic/Latina 6 2.3 
 African-American 6 2.3 
 Multiracial 10 3.8 
 Native American 1 0.4 
 Other 3 1.2 
 Missing 4 1.5 
 Total 260 100 
Orientation  
 Heterosexual 234 90.0 
 Homosexual 4 1.5 
 Bisexual 8 3.1 
 Asexual/Other 2 0.8 
 Missing 12 4.6 
 Total 260 100 	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APPENDIX A 
Informed Consent Document 
 
You are invited to participate in a research study that will examine the relationship 
between sexual functioning and sleep quality.  Dr. Eric Sprankle, clinical psychologist 
and Assistant Professor at Minnesota State University - Mankato, is conducting this 
study. 
 
Procedures 
 
If you consent to participate, you will be asked to complete a survey including questions 
about your recent sexual feelings, sleep quality, and stress.  You have the right to 
withdraw from the study at any time without penalty. The survey takes approximately 15-
25 minutes to complete. 
 
Risks and Benefits of Being in the Study 
 
Please be advised that this survey asks questions about your personal history of sexual 
functioning. Such questions may lead to negative emotions such as anxiety, distress, or 
embarrassment. Should you experience any discomfort, you have the right to stop and 
withdraw from the study at any time. 
 
There are no personal benefits of participation. 
 
Compensation 
 
Since this study is using SONA Systems, you will earn three (3) participation credits.  
Some university professors/instructors offer extra credit in their classes for participation 
in research involving SONA Systems.  However, the amount (if any) of extra credit is 
solely at the discretion of the professor/instructor.  
 
Confidentiality 
 
Responses will be anonymous. However, whenever one works with online technology 
there is always the risk of compromising privacy, confidentiality, and/or anonymity. If 
you would like more information about the specific privacy and anonymity risks posed 
by online surveys, please contact the Minnesota State University, Mankato Information 
and Technology Services Help Desk (507-389-6654) and ask to speak to the Information 
Security Manager. The principal investigator (Dr. Eric Sprankle) and his research 
assistants are the only people who will have access to the secured data. 
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Voluntary Nature of the Study 
 
Participation in this study is voluntary. Your decision whether or not to participate will 
not affect your current or future relationships with Minnesota State University. If you 
decide to participate, you are free to withdraw at any time without penalty. 
 
Contacts and Questions 
 
If you have any questions, you are encouraged to contact Dr. Eric Sprankle (the principal 
investigator) at Minnesota State University, Armstrong Hall 23, 507-389-5825 or by 
email at eric.sprankle@mnsu.edu. 
 
If you have any questions or concerns regarding this study and would like to talk to 
someone other than the researcher, or if you have questions/concerns about the treatment 
of human subjects, you are encouraged to contact the Dean of Graduate Studies and 
Research at Minnesota State University, Mankato, Dr. Barry Ries at 507-389-1242 via 
phone or at barry.ries@mnsu.edu via email. 
 
Consent 
 
By continuing on to the survey, you affirm that you have read and understood the above 
information and consent to participate. Please print this page for you records.  
 
IRBNet Approval Number: 710471 
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APPENDIX B 
Demographics Form 
 
Directions: Please provide answers to the following demographic questions. 
 
1.  Age________ 
 
2.  Race/Ethnicity___________________ 
 
3.  Gender_________________ 
 
4.  Sexual Orientation_________________ 
 
5.  Year in School___________________ 
 
6.  Relationship Status: 
 a) single 
 b) casually dating (no committed partner) 
 c) partnered (boyfriend, girlfriend, significant other, fiancé, etc) 
 d) legal partnership (married, civil union) 
 e) other 
 
 
 
 
7.  Religion is very important in my life.  
 a) strongly agree 
 b) agree 
 c) neutral 
 d) disagree  
 e) strongly disagree 
 
8.  What is your current living situation? 
 a) live alone 
 b) live alone with pet(s) 
 c) live with others (roommates, parents, significant others) 
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APPENDIX C 
Female Sexual Function Index 
 
INSTRUCTIONS: These questions ask about your sexual feelings and responses  
during the past 4 weeks. Please answer the following questions as honestly and  
clearly as possible. Your responses will be kept completely confidential. In  
answering these questions the following definitions apply:  
 
Sexual activity can include caressing, foreplay, masturbation and vaginal intercourse.  
 
Sexual intercourse is defined as penile penetration (entry) of the vagina.  
 
Sexual stimulation includes situations like foreplay with a partner, self-stimulation  
(masturbation), or sexual fantasy.  
 
CHECK ONLY ONE BOX PER QUESTION.  
Sexual desire or interest is a feeling that includes wanting to have a sexual experience, 
feeling receptive to a partner's sexual initiation, and thinking or fantasizing about having 
sex.  
 
1. Over the past 4 weeks, how often did you feel sexual desire or interest?  
[ ] Almost always or always  
[ ] Most times (more than half the time)  
[ ] Sometimes (about half the time)  
[ ] A few times (less than half the time)  
[ ] Almost never or never  
 
2. Over the past 4 weeks, how would you rate your level (degree) of sexual desire or 
interest?  
[ ] Very high  
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[ ] High  
[ ] Moderate  
[ ] Low  
[ ] Very low or none at all  
 
Sexual arousal is a feeling that includes both physical and mental aspects of sexual  
excitement. It may include feelings of warmth or tingling in the genitals, lubrication  
(wetness), or muscle contractions.  
 
3. Over the past 4 weeks, how often did you feel sexually aroused ("turned on") during 
sexual activity or intercourse?  
[ ] No sexual activity  
[ ] Almost always or always  
[ ] Most times (more than half the time)  
[ ] Sometimes (about half the time)  
[ ] A few times (less than half the time)  
[ ] Almost never or never  
 
 
 
 
 
4. Over the past 4 weeks, how would you rate your level of sexual arousal ("turn on") 
during sexual activity or intercourse?  
[ ] No sexual activity  
[ ] Very high  
[ ] High  
[ ] Moderate  
[ ] Low  
[ ] Very low or none at all  
 
5. Over the past 4 weeks, how confident were you about becoming sexually aroused 
during sexual activity or intercourse?  
[ ] No sexual activity  
[ ] Very high confidence  
[ ] High confidence  
[ ] Moderate confidence  
[ ] Low confidence  
[ ] Very low or no confidence  
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6. Over the past 4 weeks, how often have you been satisfied with your arousal 
(excitement) during sexual activity or intercourse?  
[ ] No sexual activity  
[ ] Almost always or always  
[ ] Most times (more than half the time)  
[ ] Sometimes (about half the time)  
[ ] A few times (less than half the time)  
[ ] Almost never or never  
7. Over the past 4 weeks, how often did you become lubricated ("wet") during sexual 
activity or intercourse?  
[ ] No sexual activity  
[ ] Almost always or always  
[ ] Most times (more than half the time)  
[ ] Sometimes (about half the time)  
[ ] A few times (less than half the time)  
[ ] Almost never or never  
 
8. Over the past 4 weeks, how difficult was it to become lubricated ("wet") during sexual 
activity or intercourse?  
[ ] No sexual activity  
[ ] Extremely difficult or impossible  
[ ] Very difficult  
[ ] Difficult  
[ ] Slightly difficult  
[ ] Not difficult  
 
9. Over the past 4 weeks, how often did you maintain your lubrication ("wetness") until 
completion of sexual activity or intercourse?  
[ ] No sexual activity  
[ ] Almost always or always  
[ ] Most times (more than half the time)  
[ ] Sometimes (about half the time)  
[ ] A few times (less than half the time)  
[ ] Almost never or never  
10. Over the past 4 weeks, how difficult was it to maintain your lubrication ("wetness") 
until completion of sexual activity or intercourse?  
[ ] No sexual activity  
[ ] Extremely difficult or impossible  
[ ] Very difficult  
[ ] Difficult  
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[ ] Slightly difficult  
[ ] Not difficult  
 
11. Over the past 4 weeks, when you had sexual stimulation or intercourse, how often did 
you reach orgasm (climax)?  
[ ] No sexual activity  
[ ] Almost always or always  
[ ] Most times (more than half the time)  
[ ] Sometimes (about half the time)  
[ ] A few times (less than half the time)  
[ ] Almost never or never  
 
12. Over the past 4 weeks, when you had sexual stimulation or intercourse, how difficult 
was it for you to reach orgasm (climax)?  
[ ] No sexual activity  
[ ] Extremely difficult or impossible  
[ ] Very difficult  
[ ] Difficult  
[ ] Slightly difficult  
[ ] Not difficult  
13. Over the past 4 weeks, how satisfied were you with your ability to reach orgasm 
(climax) during sexual activity or intercourse?  
[ ] No sexual activity  
[ ] Very satisfied  
[ ] Moderately satisfied  
[ ] About equally satisfied and dissatisfied  
[ ] Moderately dissatisfied  
[ ] Very dissatisfied  
 
14. Over the past 4 weeks, how satisfied have you been with the amount of emotional 
closeness during sexual activity between you and your partner?  
[ ] No sexual activity  
[ ] Very satisfied  
[ ] Moderately satisfied  
[ ] About equally satisfied and dissatisfied  
[ ] Moderately dissatisfied  
[ ] Very dissatisfied  
  
15. Over the past 4 weeks, how satisfied have you been with your sexual relationship 
with your partner?  
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[ ] Very satisfied  
[ ] Moderately satisfied  
[ ] About equally satisfied and dissatisfied  
[ ] Moderately dissatisfied  
[ ] Very dissatisfied  
 
16. Over the past 4 weeks, how satisfied have you been with your overall sexual life?  
[ ] Very satisfied  
[ ] Moderately satisfied  
[ ] About equally satisfied and dissatisfied  
[ ] Moderately dissatisfied  
[ ] Very dissatisfied  
 
17. Over the past 4 weeks, how often did you experience discomfort or pain during 
vaginal penetration?  
[ ] Did not attempt intercourse  
[ ] Almost always or always  
[ ] Most times (more than half the time)  
[ ] Sometimes (about half the time)  
[ ] A few times (less than half the time)  
[ ] Almost never or never  
 
18. Over the past 4 weeks, how often did you experience discomfort or pain following 
vaginal penetration?  
[ ] Did not attempt intercourse  
[ ] Almost always or always  
[ ] Most times (more than half the time)  
[ ] Sometimes (about half the time)  
[ ] A few times (less than half the time)  
[ ] Almost never or never  
 
 
19. Over the past 4 weeks, how would you rate your level (degree) of discomfort or pain 
during or following vaginal penetration?  
[ ] Did not attempt intercourse  
[ ] Very high  
[ ] High  
[ ] Moderate  
[ ] Low  
[ ] Very low or none at all  
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APPENDIX D 
Medical Checklist 
Medical Conditions 
Cancer (if so, what kind) 
Thyroid disorder (hypo, hyper, para) 
Bleeding problems (anemia, hemophilia, etc.) 
Blood Pressure Problems (high, low) 
GI disorders 
Heart Problems (murmur, pacemaker, etc.) 
Chronic Pain (if so, describe) 
Diabetes  
Breathing Problems (asthma, etc.) 
Neurological Problems (stroke, migraine, etc.) 
Autoimmune Disorders 
STIs 
Sleep Disorders 
Prescription Checklist 
Antidepressants 
Anxiety Medications 
Heart Medications 
Stimulant Medications (Adderall, Ritalin, etc.) 
Insulin 
Pain Medications 
 
 
Substances (please indicate amount per week beside check) 
Stimulants 
• Cocaine 
• Adderall/Ritalin 
• Methamphetamine 
Depressants 
• Alcohol 
• Heroin 
• Codeine 
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• Hydrocodone/Oxycodone 
Hallucinogens 
• MDMA/ecstasy 
• LSD 
• Psilocybin Mushrooms 
Cannabis 
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APPENDIX E 
Pittsburgh Sleep Quality Index 
 
INSTRUCTIONS:  
The following questions relate to your usual sleep habits during the past month only. 
Your answers should indicate the most accurate reply for the majority of days and nights 
in the past month. Please answer all questions.  
 
1. During the past month, what time have you usually gone to bed at night?  
BED TIME ___________ 
 
2. During the past month, how long (in minutes) has it usually taken you to fall asleep 
each night?  
NUMBER OF MINUTES ___________ 
 
3. During the past month, what time have you usually gotten up in the morning?  
GETTING UP TIME ___________ 
 
4. During the past month, how many hours of actual sleep did you get at night? (This may 
be different than the number of hours you spent in bed.)  
HOURS OF SLEEP PER NIGHT ___________ 
 
 
For each of the remaining questions, check the one best response. Please answer all 
questions.  
5. During the past month, how often have you had trouble sleeping because you . . .  
a) Cannot get to sleep within 30 minutes  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
b) Wake up in the middle of the night or early morning  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
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c) Have to get up to use the bathroom  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
d) Cannot breathe comfortably  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
e) Cough or snore loudly  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
f) Feel too cold  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
 
g) Feel too hot  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
h) Had bad dreams  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
i) Have pain  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
j) Other reason(s), please describe 
__________________________________________________________________  
How often during the past month have you had trouble sleeping because of this?  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
6. During the past month, how would you rate your sleep quality overall?  
Very good ___________  
Fairly good ___________  
Fairly bad ___________  
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Very bad ___________  
 
 
7. During the past month, how often have you taken medicine to help you sleep 
(prescribed or "over the counter")?  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
8. During the past month, how often have you had trouble staying awake while driving, 
eating meals, or engaging in social activity?  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
9. During the past month, how much of a problem has it been for you to keep up enough 
enthusiasm to get things done?  
No problem at all __________  
Only a very slight problem __________  
Somewhat of a problem __________  
A very big problem __________  
10. Do you have a bed partner or room mate?  
No bed partner or room mate __________  
Partner/room mate in other room __________  
Partner in same room, but not same bed __________  
Partner in same bed __________  
 
 
 
If you have a room mate or bed partner, ask him/her how often in the past month you 
have had… 
a) Loud snoring  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
b) Long pauses between breaths while asleep  
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Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
c) Legs twitching or jerking while you sleep  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____   
d) Episodes of disorientation or confusion during sleep  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
e) Other restlessness while you sleep; please 
describe__________________________________  
Not during the         Less than              Once or twice            Three or more  
past month _____   once a week _____      a week _____       times a week _____  
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APPENDIX F 
College Student’s Stressful Events Checklist (from Holmes & Rahe, 1967) 
___ Death of a close family member (100) 
___ Death of a close friend (73) 
___ Divorce between parents (65) 
___ Serious legal problems (63) 
___ Major personal injury or illness (63) 
___ Responsibilities for others, such as children/spouse (58) 
___ Threat to major source of income (50) 
___ Difficulty with roommate(s) (47) 
___ Change in health of a family member (45) 
___ Pregnancy (45) 
___ Sexual problems (44) 
___ Serious disagreements with parents (40) 
___ Change in lifestyle for financial reasons (39) 
___ Difficulty in identifying a major (39) 
___ Serious argument with close family member (39) 
___ Problems with a girlfriend or boyfriend (39) 
___ Having to repeat a course (37) 
___ Increased workload at school (37) 
___ Outstanding personal achievement (36) 
___ First semester in college (35) 
___ Change in living conditions (31) 
___ Serious disagreements with an instructor (30) 
___ Lower grades than expected (29) 
___ Change in sleeping habits (29) 
___ Change in social habits (29) 
___ Change in eating habits (28) 
___ Chronic car problems (26) 
___ Change in number of family get-togethers (26) 
___ Too many missed classes (25) 
___ Change in plans for a major (24) 
___ Dropped more than one class (23) 
___ Minor traffic violations (20) 
 
 
